Ironwood Pharmaceuticals, Inc. (IRWD) Ownership

$1.55

south_east
-$0.06 (-3.73%)
Day's range
$1.41
Day's range
$1.73

Ironwood Pharmaceuticals, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
ARMISTICE CAPITAL, LLC 11/17/2025 16.15 M $21.16 M   0.00% 9.99%
VANGUARD GROUP INC 11/07/2025 16.07 M $21.05 M   -0.80% 9.94%
SARISSA CAPITAL MANAGEMENT LP 11/14/2025 15.92 M $20.85 M   0.00% 9.84%
BLACKROCK, INC. 11/12/2025 12.06 M $15.80 M   0.33% 7.46%
BANK OF AMERICA CORP /DE/ 11/14/2025 11.70 M $15.32 M   248.30% 7.23%
UBS GROUP AG 11/13/2025 11.20 M $14.67 M   0.00% 6.93%
RENAISSANCE TECHNOLOGIES LLC 11/13/2025 8.35 M $10.94 M   -0.64% 5.16%
ACADIAN ASSET MANAGEMENT LLC 11/13/2025 6.50 M $8.51 M   -0.72% 4.02%
KYNAM CAPITAL MANAGEMENT, LP 11/14/2025 5.47 M $7.16 M   0.00% 3.38%
AQR CAPITAL MANAGEMENT LLC 11/14/2025 5.38 M $7.05 M   -12.77% 3.33%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 11/10/2025 4.92 M $6.44 M   34.20% 3.04%
GEODE CAPITAL MANAGEMENT, LLC 11/12/2025 3.61 M $4.74 M   3.31% 2.24%
TWO SIGMA ADVISERS, LP 11/14/2025 3.32 M $4.34 M   -2.00% 2.05%
STATE STREET CORP 11/14/2025 3.16 M $4.13 M   1.56% 1.95%
MARSHALL WACE, LLP 11/13/2025 3.14 M $4.12 M   -21.27% 1.94%
QUBE RESEARCH & TECHNOLOGIES LTD 11/14/2025 2.81 M $3.68 M   -16.24% 1.74%
TWO SIGMA INVESTMENTS, LP 11/14/2025 2.53 M $3.32 M   -7.86% 1.57%
JANE STREET GROUP, LLC 11/14/2025 2.32 M $3.04 M   33.00% 1.44%
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. 11/13/2025 2.16 M $2.83 M   -2.04% 1.34%
FEDERATED HERMES, INC. 11/03/2025 2.16 M $2.83 M   -0.92% 1.33%
JACOBS LEVY EQUITY MANAGEMENT, INC 11/17/2025 1.92 M $2.52 M   30.20% 1.19%
DEUTSCHE BANK AG\ 11/13/2025 1.53 M $2.00 M   0.26% 0.94%
NORTHERN TRUST CORP 11/14/2025 1.34 M $1.76 M   2.73% 0.83%
LOS ANGELES CAPITAL MANAGEMENT LLC 10/20/2025 1.13 M $1.48 M   -6.70% 0.70%
GOLDMAN SACHS GROUP INC 11/14/2025 1.08 M $1.42 M   -24.94% 0.67%
UBS GROUP AG 11/13/2025 811.66 K $1.06 M   170.46% 0.50%
SEI INVESTMENTS CO 11/13/2025 683.60 K $895.52 K   0.00% 0.42%
IEQ CAPITAL, LLC 11/14/2025 661.70 K $866.82 K   34.52% 0.41%
CITADEL ADVISORS LLC 11/14/2025 644.05 K $843.70 K   108.25% 0.40%
FMR LLC 11/13/2025 559.95 K $733.53 K   12.62% 0.35%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 11/10/2025 537.25 K $703.80 K   100.00% 0.33%
BANK OF NEW YORK MELLON CORP 11/03/2025 503.08 K $659.03 K   3.26% 0.31%
MORGAN STANLEY 11/14/2025 477.10 K $625.00 K   -3.43% 0.30%
D. E. SHAW & CO., INC. 11/14/2025 372.27 K $487.67 K   -77.70% 0.23%
INVESCO LTD. 11/13/2025 366.53 K $480.16 K   13.78% 0.23%
STATE OF WYOMING 11/04/2025 362.41 K $474.75 K   76.23% 0.22%
ROBECO INSTITUTIONAL ASSET MANAGEMENT B.V. 10/22/2025 343.00 K $449.33 K   -7.38% 0.21%
CERITY PARTNERS LLC 10/22/2025 339.05 K $444.15 K   -0.19% 0.21%
RUSSELL INVESTMENTS GROUP, LTD. 11/13/2025 326.57 K $429.28 K   56.36% 0.20%
GSA CAPITAL PARTNERS LLP 11/07/2025 309.53 K $405.00 K   -57.06% 0.19%
SAVANT CAPITAL, LLC 11/05/2025 309.07 K $404.88 K   15.42% 0.19%
ROYCE & ASSOCIATES LP 11/12/2025 300.62 K $393.81 K   -40.60% 0.19%
BARCLAYS PLC 11/12/2025 297.32 K $389.49 K   -18.64% 0.18%
TOROSO INVESTMENTS, LLC 11/14/2025 294.24 K $385.45 K   -5.11% 0.18%
MILLENNIUM MANAGEMENT LLC 11/14/2025 250.12 K $327.66 K   159.64% 0.15%
CWM, LLC 10/15/2025 232.79 K $305.00 K   27.36% 0.14%
RHUMBLINE ADVISERS 11/06/2025 223.23 K $292.42 K   3.53% 0.14%
OMERS ADMINISTRATION CORP 11/14/2025 215.11 K $281.79 K   0.00% 0.13%
ALLIANCEBERNSTEIN L.P. 11/14/2025 199.52 K $261.37 K   0.00% 0.12%
EXCHANGE TRADED CONCEPTS, LLC 10/14/2025 195.73 K $256.41 K   -42.69% 0.12%

Ironwood Pharmaceuticals, Inc. institutional Ownership - FAQ's

During the previous two years, 267 institutional investors and hedge funds held shares of Ironwood Pharmaceuticals, Inc.. The most heavily invested institutionals were:

ARMISTICE CAPITAL, LLC: 16.15 M

VANGUARD GROUP INC: 16.07 M

Sarissa Capital Management LP: 15.92 M

BlackRock, Inc.: 12.06 M

BANK OF AMERICA CORP /DE/: 11.7 M

RENAISSANCE TECHNOLOGIES LLC: 8.35 M

92.10% of Ironwood Pharmaceuticals, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 198.33 M shares in the last 24 months. This purchase volume represents approximately $307.41 M in transactions.